article thumbnail

Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?

STAT

Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. Long Covid has long eluded scientists looking for its cause.

Immunity 363
article thumbnail

STAT+: Study finds supplements of amino acid taurine slow aging in mice and monkeys

STAT

In a 1975 paper, published in Science , Hayes and his colleagues definitively established that taurine deficiency was to blame for retinal degeneration in cats, a landmark discovery that forever changed feline nutrition and eventually launched the Garfield-endorsed Alpo cat food. Continue to STAT+ to read the full story…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vertex to acquire Alpine Immune Sciences for $4.9bn

Pharmafile

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

article thumbnail

4th Antigen Specific Immune Tolerance Summit

pharmaphorum

The 4 th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. This is the industry’s definitive antigen specific drug development forum.

article thumbnail

Merck acquires Prometheus Biosciences

Express Pharma

Merck, known as MSD outside the US and Canada, and Prometheus Biosciences announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8

article thumbnail

AstraZeneca to acquire Gracell Biotechnologies

Express Pharma

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies, a global clinical-stage biopharma company developing innovative cell therapies for the treatment of cancer and autoimmune diseases. Future applications of this technology may also include rare diseases.” per ordinary share (equivalent to $1.50

Immunity 105
article thumbnail

SAEM Clinical Images Series: Rapidly Spreading Rash

ALiEM - Pharm Pearls

The regiSCAR diagnostic criteria is the most used diagnostic criteria and is based on a scoring system for possible, probable, or definite diagnosis. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Case Question: How should this condition be managed? Int J Mol Sci.

Immunity 177